Monsanto
- All
- News
- Videos
-
Monsanto Patent Victory Seen As A Boost For Biotech Investment In India
The Supreme Court ruled on Tuesday that Monsanto can claim patents on its genetically modified (GM) cotton seeds, a victory for the US company that is expected to encourage biotechnology firms to step up investment in India.
-
Monsanto Owner Bayer Says Glyphosate Is "Safe" After US Court Ruling
Bayer, the German owner of Monsanto, said Saturday that glyphosate is "safe" after a California jury ordered the US chemical giant to pay nearly $290 million for failing to warn a dying groundskeeper that the product, a component of weedkiller Roundup, might cause cancer.
-
US Chemical Company Monsanto To Pay $290 Million To Cancer Patient
A California jury ordered chemical giant Monsanto to pay nearly $290 million Friday for failing to warn a dying groundskeeper that its weed killer Roundup might cause cancer.
-
Monsanto Appeals To Supreme Court Over Genetically Modified Cotton Patents
Monsanto Co has appealed to the Supreme Court against a ruling by the Delhi High Court which decreed last month that the world's biggest seed maker cannot claim patents on its genetically modified or GM cotton seeds, a company spokesman said on Friday.
-
Government Cuts Monsanto's GM Cotton Seed Royalty By 20%
In 2016, the agriculture ministry had cut Monsanto's royalties by more than 70%.
-
Andhra Pradesh's Battle To Save Farmers - From Illegal Seeds
Andhra Pradesh, country's top cotton-growing state, has told two local companies that seeds they sold to farmers may have contained traces of an unapproved GM strain from Monsanto, according to government notices seen by Reuters that warn of action against the firms.
-
'US In UP': Big American Firms Meet Yogi Adityanath Tomorrow
As a number of international establishments have been exploring investment opportunities in Uttar Pradesh, Chief Minister Yogi Adityanath will tomorrow meet representatives of major American companies including Facebook, Adobe, Coca Cola, Mastercard, Monsanto, Uber, Honeywell, P&G, Oracle and GE Health and Cargill, in Lucknow.
-
Andhra Investigates Planting Of Monsanto's Unapproved GM Cotton
One of India's biggest cotton-growing states has formed a panel to investigate how 15 percent of the state's cotton acreage has been planted with a non-approved genetically modified strain developed by Monsanto and may bring criminal charges.
-
EU Parliament May Deny Access To Monsanto
The European Parliament has been asked by its political leaders to deny access to executives and lobbyists for US agro-chemicals giant Monsanto, a parliament spokesman said Friday. The leaders of the parliament's political groups issued the appeal after the firm turned down an invitation to a hearing over claims Monsanto influenced scientific resea...
-
Donald Trump's CEO Meetings Raise Ethics Questions
President-elect Donald Trump's meetings with CEOs seeking federal approval for major mergers are raising red flags for ethics lawyers concerned about the possible erosion of a firewall between the incoming White House and regulators reviewing those billion-dollar deals.
-
Monsanto Patent Victory Seen As A Boost For Biotech Investment In India
The Supreme Court ruled on Tuesday that Monsanto can claim patents on its genetically modified (GM) cotton seeds, a victory for the US company that is expected to encourage biotechnology firms to step up investment in India.
-
Monsanto Owner Bayer Says Glyphosate Is "Safe" After US Court Ruling
Bayer, the German owner of Monsanto, said Saturday that glyphosate is "safe" after a California jury ordered the US chemical giant to pay nearly $290 million for failing to warn a dying groundskeeper that the product, a component of weedkiller Roundup, might cause cancer.
-
US Chemical Company Monsanto To Pay $290 Million To Cancer Patient
A California jury ordered chemical giant Monsanto to pay nearly $290 million Friday for failing to warn a dying groundskeeper that its weed killer Roundup might cause cancer.
-
Monsanto Appeals To Supreme Court Over Genetically Modified Cotton Patents
Monsanto Co has appealed to the Supreme Court against a ruling by the Delhi High Court which decreed last month that the world's biggest seed maker cannot claim patents on its genetically modified or GM cotton seeds, a company spokesman said on Friday.
-
Government Cuts Monsanto's GM Cotton Seed Royalty By 20%
In 2016, the agriculture ministry had cut Monsanto's royalties by more than 70%.
-
Andhra Pradesh's Battle To Save Farmers - From Illegal Seeds
Andhra Pradesh, country's top cotton-growing state, has told two local companies that seeds they sold to farmers may have contained traces of an unapproved GM strain from Monsanto, according to government notices seen by Reuters that warn of action against the firms.
-
'US In UP': Big American Firms Meet Yogi Adityanath Tomorrow
As a number of international establishments have been exploring investment opportunities in Uttar Pradesh, Chief Minister Yogi Adityanath will tomorrow meet representatives of major American companies including Facebook, Adobe, Coca Cola, Mastercard, Monsanto, Uber, Honeywell, P&G, Oracle and GE Health and Cargill, in Lucknow.
-
Andhra Investigates Planting Of Monsanto's Unapproved GM Cotton
One of India's biggest cotton-growing states has formed a panel to investigate how 15 percent of the state's cotton acreage has been planted with a non-approved genetically modified strain developed by Monsanto and may bring criminal charges.
-
EU Parliament May Deny Access To Monsanto
The European Parliament has been asked by its political leaders to deny access to executives and lobbyists for US agro-chemicals giant Monsanto, a parliament spokesman said Friday. The leaders of the parliament's political groups issued the appeal after the firm turned down an invitation to a hearing over claims Monsanto influenced scientific resea...
-
Donald Trump's CEO Meetings Raise Ethics Questions
President-elect Donald Trump's meetings with CEOs seeking federal approval for major mergers are raising red flags for ethics lawyers concerned about the possible erosion of a firewall between the incoming White House and regulators reviewing those billion-dollar deals.
